Safety issues and prospects for future generations of PPAR modulators
Rubenstrunk, Anne, Hanf, Rémy, Hum, Dean W., Fruchart, Jean-Charles, Staels, Bart
Published in Biochimica et biophysica acta (01.08.2007)
Published in Biochimica et biophysica acta (01.08.2007)
Get full text
Journal Article
Next-Generation Sequencing (NGS) of two independent cohorts identifies eleven circulating miRNAs for diagnosis of NASH and fibrosis
Francque, S, Cordonnier, G, Texier, F, Ratziu, V, Harrison, S, Bedossa, P, Anstee, Q, Roudot, A, Megnien, S, Hum, D, Staels, B, Chaumat, P, Hanf, R, Sanyal, A
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article
A new non-invasive diagnostic score to monitor change in disease activity and predict fibrosis evolution in patients with NASH
Harrison, S, Praca, E, Brozek, J, Cordonnier, G, Sudrik, F.B, Roudot, A, Bedossa, P, Ratziu, V, Staels, B, Hum, D, Megnien, S, Chaumat, P, Hanf, R, Sanyal, A
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article
A New Method including the Quantification of Circulating Mirnas Allows the Efficient Identification of Nash Patients at Risk who should be Treated
Sanyal, A, Cordonnier, G, Brozek, J, Roudot, A, Deledicque, S, Barbazanges, M, Praca, E, Sudrik, F.B, Megnien, S, Hanf, R, Staels, B, Bedossa, P, Ratziu, V, Hum, D, Darteil, R
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article
Relationship between Baseline Hepatic Disease Severity and the Cardiometabolic and Anti-Inflammatory Effects of Elafibranor in Patients with Non-Alcoholic Steatohepatitis
Francque, S.M, Harrison, S.A, Sanyal, A, Bedossa, P, Serfaty, L, Romero-Gomez, M, Boursier, J, Abdelmalek, M, Caldwell, S, Drenth, J, Anstee, Q, Hum, D, Hanf, R, Roudot, A, Megnien, S, Staels, B, Ratziu, V
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article
PLPNA3 Status in Nash is Associated with Increased Histological Severity at Baseline but Not with Response to Therapy in the Golden-505 Elafibranor Trial
Ratziu, V, Francque, S, Harrison, S, Sanyal, A, Bedossa, P, Serfaty, L, Romero-Gomez, M, Boursier, J, Abdelmalek, M, Caldwell, S, Drenth, J, Hum, D, Hanf, R, Roudot, A, Megnien, S, Staels, B, Anstee, Q
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article
A Post-Hoc Analysis ofthe Golden505 Trial Demonstrates Histological and Cardiometabolic Efficacy of Elafibranor-120 Mg in Patients with Moderate or Severe Nash That Are Eligible for Pharmacotherapy
Ratziu, V, Harrison, S, Francque, S, Bedossa, P, Anstee, Q, Serfaty, L, Romero-Gomez, M, Boursier, J, Abdelmalek, M, Caldwell, S, Drenth, J, Hum, D, Hanf, R, Roudot, A, Megnien, S, Sanyal, A, Staels, B
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article
1409 THE NEW DUAL PPARα/δ AGONIST GFT505 IMPROVES HEPATIC INSULIN RESISTANCE AND DECREASES SERUM LIVER ENZYMES IN ABDOMINALLY OBESE PATIENTS
Cariou, B, Hanf, R, Lambert-Porcheron, S, Zaïr, Y, Flet, L, Staels, B, Laville, M
Published in Journal of hepatology (01.04.2012)
Published in Journal of hepatology (01.04.2012)
Get full text
Journal Article
CA-167: Impact des statines sur le risque de diabète de type 2 (DT2) chez des sujets prédiabétiques : résultats de l'étude prospective IT-DIAB
Smati, S, Hanf, M, Pichelin, M, Richard, A, Bressolette, B, Jacquin, V, You, M, Zaïr, Y, Hanf, R, Authier, C, Breton, G, Cariou, B
Published in Diabetes & metabolism (01.03.2016)
Published in Diabetes & metabolism (01.03.2016)
Get full text
Journal Article
Cyclo‐oxygenase and lipoxygenase pathways in mast cell dependent‐neurogenic inflammation induced by electrical stimulation of the rat saphenous nerve
Le Filliatre, G, Sayah, S, Latournerie, V, Renaud, J F, Finet, M, Hanf, R
Published in British journal of pharmacology (01.04.2001)
Published in British journal of pharmacology (01.04.2001)
Get full text
Journal Article
O45 Le GFT505, un co-agoniste PPARα/δ, améliore la sensibilité périphérique et hépatique à l’insuline chez des patients obèses insulinorésistants
Cariou, B, Hanf, R, Ambert-Porcheron, S, Zaïr, Y, Flet, L, Vidal, H, Staels, B, Laville, M
Published in Diabetes & metabolism (26.03.2013)
Published in Diabetes & metabolism (26.03.2013)
Get full text
Journal Article
Expression profiling of 728 miRNAs in a NASH model identifies excellent correlations of hepatic and circulation miR-34a levels with histological lesions in rats and men
Cordonnier, G., Texier, F., Benoit, N., Nathalie, D., Sudrick, F.B., Brozek, J., Hanf, R., Sanyal, A.
Published in Journal of hepatology (01.04.2018)
Published in Journal of hepatology (01.04.2018)
Get full text
Journal Article
THU-482 - Expression profiling of 728 miRNAs in a NASH model identifies excellent correlations of hepatic and circulation miR-34a levels with histological lesions in rats and men
Cordonnier, G., Texier, F., Benoit, N., Nathalie, D., Sudrick, F.B., Brozek, J., Hanf, R., Sanyal, A.
Published in Journal of hepatology (01.04.2018)
Published in Journal of hepatology (01.04.2018)
Get full text
Journal Article
Histamine‐induced biphasic macromolecular leakage in the microcirculation of the conscious hamster: evidence for a delayed nitric oxide‐dependent leakage
Gimeno, G, Carpentier, P H., Desquand‐Billiald, S, Hanf, R, Finet, M
Published in British journal of pharmacology (01.03.1998)
Published in British journal of pharmacology (01.03.1998)
Get full text
Journal Article
Validation of NIS4 algorithm for detection of NASH at risk of cirrhosis in 467 NAFLD patients prospectively screened for inclusion in the RESOLVE-IT trial
Hanf, R., Pierre, C., Zouher, M., Cordonnier, G., Brozek, J., Praca, E., Sudrick, F.B., Bedossa, P., Anstee, Q., Francque, S., Harrison, S., Ratziu, V., Megnien, S., Roudot, A., Hum, D., Sanyal, A.
Published in Journal of hepatology (01.04.2018)
Published in Journal of hepatology (01.04.2018)
Get full text
Journal Article